These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37984710)

  • 21. Eliminating cccDNA to cure hepatitis B virus infection.
    Zoulim F; Testoni B
    J Hepatol; 2023 Apr; 78(4):677-680. PubMed ID: 36717025
    [No Abstract]   [Full Text] [Related]  

  • 22. KASL clinical practice guidelines for management of chronic hepatitis B.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2019 Jun; 25(2):93-159. PubMed ID: 31185710
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in new antivirals for chronic hepatitis B.
    Tang Y; Liang H; Zeng G; Shen S; Sun J
    Chin Med J (Engl); 2022 Feb; 135(5):571-583. PubMed ID: 35120358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HBV cure: why, how, when?
    Levrero M; Testoni B; Zoulim F
    Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
    Wiegand J; Patel K; Tillmann HL
    Hepatology; 2009 Oct; 50(4):1314; author reply 1314. PubMed ID: 19676132
    [No Abstract]   [Full Text] [Related]  

  • 26. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments.
    Laupèze B; Vassilev V; Badur S
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1135-1147. PubMed ID: 37847193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.
    King WC; Sterling RK; Hinerman AS; Lok ASF; Cloherty GA; Ghany MG;
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1957-1959. PubMed ID: 35850413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Durability of Interferon-induced Hepatitis B Surface Antigen Seroclearance.
    Wu Y; Liu Y; Lu J; Cao Z; Jin Y; Ma L; Geng N; Ren S; Zheng Y; Shen C; Chen X
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):514-516.e2. PubMed ID: 30981007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bepirovirsen-A New Therapy for Chronic Hepatitis B Infection.
    Lens S
    Gastroenterology; 2023 Jul; 165(1):301-302. PubMed ID: 36801391
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
    Baugh SDP
    Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical cure strategy for hepatitis B: immunomodulatory therapy].
    Xie Q; Ning Q; Wang GQ; Chen CW; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):644-648. PubMed ID: 32911900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A 2020 update on the progress of treatment and new drug clinical trials for hepatitis B].
    Jia JD; Niu JQ; You H; Kong YY; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):97-101. PubMed ID: 33685074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B cure: How and when.
    Dusheiko G
    Liver Int; 2021 Jun; 41 Suppl 1():24-29. PubMed ID: 34155803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Are phyllanthus species effective in hepatitis B?].
    Rakowitz B
    Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1460. PubMed ID: 21732258
    [No Abstract]   [Full Text] [Related]  

  • 35. High dose lamivudine and hepatitis B.
    Musher DR; Wasser WG; Saggi SJ
    Am J Gastroenterol; 1999 Nov; 94(11):3372. PubMed ID: 10566751
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis B core-related antigen: Are we near a treatment endpoint?
    Gupta T
    World J Gastroenterol; 2022 Jul; 28(27):3532-3534. PubMed ID: 36158266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New serological markers as a monitoring indicator for clinical cure of chronic hepatitis B].
    Wang XM; Niu JQ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):565-567. PubMed ID: 30317786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of different viral biomarkers on the management of chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Apr; 29(2):263-276. PubMed ID: 36655304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A "sandwich" strategy for functional cure of chronic hepatitis B.
    Wang XY; Wen YM
    Emerg Microbes Infect; 2018 May; 7(1):91. PubMed ID: 29769522
    [No Abstract]   [Full Text] [Related]  

  • 40. Latest developments in the treatment of hepatitis B.
    Dandri M; Petersen J
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.